MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
105 Approvals
Showing 1 to 20 of 105 approvalsPage 1 of 6

Zynlonta

Authorisation: Dec 20, 2022

Plerixafor Accord

Authorisation: Dec 16, 2022

Ebvallo

Authorisation: Dec 16, 2022

Eladynos

Authorisation: Dec 12, 2022

Pemetrexed Baxter

Authorisation: Dec 9, 2022

Locametz

Authorisation: Dec 9, 2022

Pluvicto

Authorisation: Dec 9, 2022

Qdenga

Authorisation: Dec 5, 2022

Qdenga

Authorisation: Dec 5, 2022

Mycapssa

Authorisation: Dec 2, 2022

Enjaymo

Authorisation: Nov 15, 2022

Sorafenib Accord

Authorisation: Nov 9, 2022

Ximluci

Authorisation: Nov 9, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.